Medifast (NYSE: MED) reported Q4 EPS of $1.09, $0.19 better than the analyst estimate of $0.90. Revenue for the quarter came in at $191 million versus the consensus estimate of $184.17 million.

For earnings history and earnings-related data on Medifast (MED) click here.